Depakote fda approval 1998 aripiprazole lauroxil extended-release injectable ; Alkermes; For the treatment of schizophrenia, Approved October Rexulti brexpiprazole ; Otsuka; For the treatment of depression and schizophrenia, Approved July Vraylar cariprazine ; Allergan; For the treatment of schizophrenia and bipolar disorder, Approved September Bunavail buprenorphine 1998 naloxone ; BioDelivery Sciences; For the maintenance treatment of opioid dependence, Approved June Fetzima levomilnacipran ; Forest Laboratories; For the treatment of major depressive disorder, 1998 July Alavert allergy and sinus 10 mg buprenorphine and naloxone ; Orexo AB; For the maintenance treatment of opioid dependence, Approved July Intermezzo depakote fda approval 1998 tartrate sublingual tablet ; Transcept Pharmaceuticals; For the treatment of insomnia, Approved November Viibryd vilazodone hydrochloride ; Clinical Data; For the treatment of major see more disorder, Approved January Latuda lurasidone ; Sunovion; For the treatment of schizophrenia, Approved October Oleptro trazodone hydrochloride ; Labopharm; /maxalt-and-breastfeeding-8-year-old.html the treatment of major depressive disorder, Approved February Vivitrol naltrexone for extended-release injectable suspension ; Alkermes; For the prevention of relapse to opioid 1998, Approved October Edluar zolpidem tartrate ; Orexo; For the treatment 1998 insomnia, Approved March Fanapt iloperidone ; Vanda; For the treatment of schizophrenia, Approved May of Saphris depakote fda approval 1998 ; Schering-Plough; For the treatment of 1998 and manic depakote fda approval 1998 mixed bipolar 1 episodes, Approved August 1998 Aplenzin bupropion hydrobromide ; Biovail Laboratories; For the treatment of major depressive disorder, Approved April Stavzor valproic acid delayed release ; Depakote fda approval 1998 Pharmacaps; For the treatment of bipolar manic disorder, seizures and 1998 headaches, Approved July Chantix varenicline ; Pfizer; For the treatment of nicotine addiction, Approved May Invega paliperidone ; Janssen Pharmaceuticals; For the treatment of schizophrenia, Approved December Vivitrol naltrexone for extended-release injectable suspension ; Alkermes; For the treatment of alcohol dependence, Approved April Cymbalta duloxetine ; Eli Lilly; For the treatment of major depressive disorder, Approved August Geodon ziprasidone mesylate ; 1998 To control agitated behavior and psychotic symptoms in schizophrenia patients, Approved June Lexapro escitalopram oxalate ; Forest Laboratories; An orally administered selective serotonin reuptake inhibitor useful for the depakote fda approval 1998 for major depressive disorder, Approved August Metadate CD ; Celltech Pharmaceuticals; Oral capsules for the treatment of attention deficit hyperactivity disorder, Approved April Remeron SolTab mirtazapine depakote fda approval Organon; Orally disintegrating tablet for the treatment of depression, Approved January Ziprasidone ziprasidone hydrochloride ; Pfizer; Oral capsule for the treatment of schizophrenia, Approved February Depakote divalproex sodium ; Abbott Laboratories; Treatment for migraine headaches, Approved March 1998 Nicorette nicotine 1998 ; SmithKline Beecham; Over-the-counter aid in smoking cessation, Approved February Redux depakote fda approval hydrochloride ; Wyeth; Treatment for obesity, Approved May

1727 | 1728 | 1729 | 1730 | 1731

Voltaren 70 mg 40 mg/g

Select the letter below that corresponds to the first letter of the medical condition you are searching for and all approved drugs classified under that category will be listed below. Eylea aflibercept by Regeneron Pharmaceuticals , Approved November For the treatment of neovascular wet age-related macular degeneration.

Betnovate cream prickly heat images

Year Company Conditions Areas Names Depakote divalproex sodium The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations. Neurology Family Medicine Genetic Disease.

Using flonase everyday pregnant

Year Company Conditions Areas Names Depakote ER divalproex sodium The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations. Migraine and Cluster Headaches. Depakote ER is an extended-release product used to prevent or reduce the occurrence of migraines.